A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota

Trial Profile

A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Mar 2017

At a glance

  • Drugs Trichuris suis ova (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Mar 2016 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 28 Apr 2015 Planned End Date changed from 1 Sep 2016 to 1 Nov 2015 as per ClinicalTrials.gov record.
    • 28 Apr 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Nov 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top